The results indicate that GsRb1 is a potential drug candidate with high specificity/selectivity on MMP-9 inhibition and inflammatory alleviation, especially for cardiac remodeling and hepatocellular carcinoma metastasis. This evidence concerns the gene MMP9 and hepatocellular carcinoma.